Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5027 total record number 57 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 28 out of 503
5027 citations found

ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D

Du, G;Healy, LB;David, L;Walker, C;El-Baba, TJ;Lutomski, CA;Goh, B;Gu, B;Pi, X;Devant, P;Fontana, P;Dong, Y;Ma, X;Miao, R;Balasubramanian, A;Puthenveetil, R;Banerjee, A;Luo, HR;Kagan, JC;Oh, SF;Robinson, CV;Lieberman, J;Wu, H;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Structure-Based Design and Synthesis of Lipid A Derivatives to Modulate Cytokine Responses

Verpalen, ECJM;Brouwer, AJ;Wolfert, MA;Boons, GJ;

Product: LPS from Escherichia coli O55:B5

  • Biological materials.

    E. coli 055 : B5 LPS (Lot # 20318 A4) was obtained from List Biologicals. All data presented in this study were generated with the same batch of E. coli 055 : B5 LPS. The synthetic lipid A derivatives were reconstituted as 2 mg/mL in 90 % THF/10 % water. Stock solutions in small aliquots were stored at −80 °C.

    Product #203A – LPS from Escherichia coli O55:B5

Galaninergic and hypercapnia-activated neuronal projections to the ventral respiratory column

Dereli, AS;Oh, AYS;McMullan, S;Kumar, NN;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • Retrograde tracer microinjections into the VRC

    … A 20 nl unilateral injection of cholera toxin B (CTB) was pneumatically injected over 3–5 min into the VRC using a glass capillary micropipette of diameter 20–40 μm at 6.2 mm deep to lambda (1%; List Biological, Campbell, CA) (Fig. 1). The pipette was left in place for 5 min before withdrawal. At the conclusion of injections, the incision was closed with silk sutures, isoflurane was discontinued, and once ambulatory, animals were returned to their home cage for 3–5 days to allow for CTB transport. Carprofen (5 mg/kg, s.c.) was administered once daily for pain relief.

    Product #104 – Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Intranasal Resveratrol Nanoparticles Enhance Neuroprotection in a Model of Multiple Sclerosis

Shamsher, E;Khan, RS;Davis, BM;Dine, K;Luong, V;Cordeiro, MF;Shindler, KS;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • 4.3. Experimental Autoimmune Encephalomyelitis Mouse Model

    EAE was induced as described previously [6,16]. Mice were anesthetized with an intraperitoneal injection of a solution containing 0.2 mL of 10 mg/mL ketamine (Sigma, St. Louis, MO, USA) and 1 mg/mL xylazine (Sigma). A total of 300 µg of MOG peptide 35–55 emulsified in complete Freund’s adjuvant (CFA; BD Difco, Franklin Lakes, NJ, USA) with 2.5 mg/mL mycobacterium tuberculosis (Difco) was subcutaneously injected at different sites on their back (2 doses of 150 µg each) to immunize them. Control, non-EAE mice (n = 5) were injected with an equivalent volume of PBS (1X phosphate-buffered saline, PH 7.4; Corning, Corning, NY, USA) diluted in CFA. A total of 200 ng of pertussis toxin (List Biological, Campbell, CA, USA) was injected intraperitoneally in control and immunized mice at immunization and 2 days post-immunization. …

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Inhibition of adenylyl cyclase by GTPase-deficient Gαi is mechanistically different from that mediated by receptor-activated Gαi

Chung, YK;Chan, HY;Lee, TY;Wong, YH;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Gut microbiome changes in mouse, Mongolian gerbil, and hamster models following Clostridioides difficile challenge

Wan, S;You, P;Shi, Q;Hu, H;Zhang, L;Chen, L;Wu, Z;Lin, S;Song, X;Luo, Y;Wang, Y;Ju, F;Jin, D;Chen, Y;

Product: Toxin B from Clostridium difficile

  • 2.4 Detection of TcdB toxins in stool samples via ELISA

    TcdB toxins in stool samples from the control and infected rodents were detected via ELISA. The collected stool samples were suspended in 10% (wt/vol) PBS (pH 7.4). Thereafter, the fecal suspensions were seeded into 96-well plates and incubated at 4°C overnight. This was followed by washing with PBST (PBS pH 7.4 + 0.05% tween-20) after which the plate was blocked with 0.5% BSA at 37°C for 2 h. TcdB polyclonal antibodies (List Biological Laboratories Campbell, CA, United States; Chicken IgY, 1:1000 dilution ratio) were used for the first hybridization process, while goat anti-chicken IgY secondary antibody and horse radish peroxidase (Invitrogen, Carlsbad, CA, USA; 1:5000 dilution ratio) were used for the second hybridization. The ELISA-TMB Chromogenic Reagent kit (Sangon, Shanghai, China) was used to determine the absorbance at 450 nm. Pure TcdB toxin (List Biological Laboratories) was used as the positive control, and standard curves were generated.

    Product #155 – Toxin B from Clostridium difficile
    Product #754A – Anti-Clostridium difficile Toxin B (Chicken lgY)

Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor

Gaitonde, S;Avet, C;Revenga, M;Blondel-Tepaz, É;Shahraki, A;Pastor, A;Talagayev, V;Robledo, P;Kolb, P;Selent, J;González?Maeso, J;Bouvier, M;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Positive regulation of Vav1 by Themis controls CD4 T cell pathogenicity in a mouse model of central nervous system inflammation

Marrocco, R;Bernard, I;Joulia, E;Barascud, R;Dejean, AS;Lesourne, R;Saoudi, A;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

MicroRNAs -122 and -1247 restrain the pathogenicity of effector CD4+ T cells in autoimmune inflammation

Silva-Santos, B;Cunha, C;Romero, P;Inácio, D;Pais, A;Pelicano, C;Costa, M;Mensurado, S;Gonçalves-Sousa, N;Papotto, P;Neves, D;Sobral, D;Enguita, F;Gomes, A;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Transient Seizure Clusters and Epileptiform Activity Following Widespread Bilateral Hippocampal Interneuron Ablation

Dusing, MR;LaSarge, CL;Drake, AW;Westerkamp, GC;McCoy, C;Hetzer, SM;Kraus, KL;Pedapati, EV;Danzer, SC;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • Experiment 1: diphtheria toxin treatment and EEG monitoring of Vgat ablation mice.

    EEG-implanted mice injected with AAV9-CAG-frt-DTr were allowed to recover for 2 weeks after surgery (Table 1, Experiment 1), followed by a week of baseline 24/7 video-EEG monitoring. Beginning in the fourth week after virus injections, mice were treated with diphtheria toxin
    or saline. Diphtheria toxin (List Biological Laboratories, #150) was prepared in sterile normal saline at 0.1 mg/ml and stored
    frozen in aliquots at −80°C. Diphtheria toxin was diluted to a concentration of 5 ng/µl the day of use in normal saline. Mice were injected intraperitoneally at 20 µg/kg with diphtheria toxin once per day for 5 d. Video-EEG monitoring continued through treatment and for an additional 2–4 weeks after treatment.

    Product #150 – Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae